Galli J, Calò L, Ardito F, Imperiali M, Bassotti E, Fadda G, Paludetti G
Institute of Otorhinolaryngology, Catholic University of the Sacred Heart, Rome, Italy.
Acta Otorhinolaryngol Ital. 2007 Jun;27(3):134-8.
Aim of the present study was to identify bacterial biofilms in tissue samples obtained from paediatric patients undergoing surgical treatment, for chronic and recurrent adeno-tonsillitis, not responding to repeated cycles of selective medical antibiotic and anti-inflammatory treatment and to assay the ability of Haemophilus influenzae strains, most frequently identified in the culture examinations, to grow as biofilm in vitro. Overall, 25 surgical specimens (15 adenoids, 10 tonsils) were examined from the upper respiratory tract, from 15 paediatric patients (mean age 6 years). All patients were affected by recurrent and/or chronic adenoiditis and adenotonsillitis unresponsive to selective antibiotic and anti-inflammatory therapy. Tissues were cultured using conventional methods and subjected to scanning electron microscopy for detection of biofilm. Haemophilus influenzae strains, were cultured on 96-sterile well polystyrene microtitre plates (CELLSTAR-greiner bio-one) and stained with 1% crystal violet to quantify biofilm production. Bacterial cocci attached to the tissue surface and organized in colonies, with a morphology consistent with bacterial coccoid biofilms, were observed in all adenoid (15/15) and in 6/10 tonsil samples. Haemophilus influenzae isolates from 12/25 (48%) of our tissue samples scored a percent transmittance (%T(bloc)) > 50, displaying a high capacity to form biofilms (level 4). In conclusion identification of bacterial biofilms in chronic and/or recurrent paediatric upper airway inflammatory processes and the capacity to produce biofilm in vitro, demonstrated by Haemophilus influenzae (the most frequently identified bacteria in our samples), could be related to the aetiopathogenic role of biofilms in chronic inflammatory mucosal reactions and to the resistance of these infections to selective antibiotic therapy.
本研究的目的是在接受手术治疗的儿科患者的组织样本中鉴定细菌生物膜,这些患者患有慢性和复发性腺扁桃体炎,对反复的选择性医学抗生素和抗炎治疗周期无反应,并检测在培养检查中最常鉴定出的流感嗜血杆菌菌株在体外形成生物膜的能力。总体而言,从15名儿科患者(平均年龄6岁)的上呼吸道检查了25个手术标本(15个腺样体,10个扁桃体)。所有患者均患有复发性和/或慢性腺样体炎以及对选择性抗生素和抗炎治疗无反应的腺扁桃体炎。使用传统方法对组织进行培养,并进行扫描电子显微镜检查以检测生物膜。将流感嗜血杆菌菌株在96孔无菌聚苯乙烯微量滴定板(CELLSTAR-葛莱娜生物-one)上培养,并用1%结晶紫染色以量化生物膜的产生。在所有腺样体样本(15/15)和6/10的扁桃体样本中,均观察到细菌球菌附着在组织表面并形成菌落,其形态与细菌球菌生物膜一致。我们组织样本中12/25(48%)的流感嗜血杆菌分离株的透光率百分比(%T(bloc))>50,显示出高生物膜形成能力(4级)。总之,在慢性和/或复发性儿科上呼吸道炎症过程中鉴定细菌生物膜以及流感嗜血杆菌(我们样本中最常鉴定出的细菌)在体外产生生物膜的能力,可能与生物膜在慢性炎症性黏膜反应中的致病作用以及这些感染对选择性抗生素治疗的耐药性有关。